Medicare spending on oncology drugs per beneficiary nearly doubled from 2016 to 2020, although the number of patients using these drugs has remained fairly stable.
Medscape Medical News
Medicare spending on oncology drugs per beneficiary nearly doubled from 2016 to 2020, although the number of patients using these drugs has remained fairly stable.
Medscape Medical News
